• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Thyrocare Share Price

    Thyrocare Technologies Share PriceThyrocare Technologies

    Small Cap 4.8k Result
    ₹568.3
    14.5 (2.62%)
    As on 30 September, 2023 | 18:51 BSE: 539871 NSE: THYROCAREISIN: INE594H01019

    Thyrocare Technologies Performance

    Day Range

    • Low 554.95
    • High 574.95
    568.3

    52 Week Range

    • Low 415.4
    • High 768.25
    568.3
    • Open Price556.6
    • Previous Close553.8
    • Volume70186

    Start SIP in Thyrocare Technologies

    Start SIP

    Thyrocare Technologies Share Price

    • Over 1 Month 2.84%
    • Over 3 Month 8.9%
    • Over 6 Month 34.91%
    • Over 1 Year -19.09%

    Thyrocare Technologies Key Statistics

    P/E Ratio 50.1
    PEG Ratio -0.9
    Market Cap Cr 3,008
    Price to Book Ratio 5.6
    EPS 10.4
    Dividend 3.2
    Relative Strength Index 55.48
    Money Flow Index 61.99
    MACD Signal 2.53
    Average True Range 17.15

    Thyrocare Technologies Investment Rating

    • Master Rating:

    • Thyrocare Technologies has an operating revenue of Rs. 533.77 Cr. on a trailing 12-month basis. An annual revenue de-growth of -13% needs improvement, Pre-tax margin of 17% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 9% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Thyrocare Technologies Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 124125117125119123
    Operating Expenses Qtr Cr 9010291968587
    Operating Profit Qtr Cr 332326303437
    Depreciation Qtr Cr 999889
    Interest Qtr Cr 111111
    Tax Qtr Cr 855869
    Net Profit Qtr Cr 171013142020
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 492569
    Operating Expenses Annual Cr 374331
    Operating Profit Annual in Cr 112231
    Depreciation Cr 3428
    Interest Annual Cr 22
    Tax Annual Cr 2455
    Net Profit Annual Cr 57152
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 120106
    Cash from Investing Activity Annual Cr -32-12
    Cash from Financing Annual Activity Cr -88-87
    Net Cash Flow Annual Cr 16
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 521521
    Fixed Assets Annual Cr 157152
    Total Non Current Assets Annual Cr 377366
    Total Current Assets Annual Cr 235231
    Total Assets Annual Cr 612597
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 9898
    ROE Annual % 1129
    ROCE Annual % 1539
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2442
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 135136128135128131
    Operating Expenses Qtr Cr 1011111001039293
    Operating Profit Qtr Cr 342528323638
    Depreciation Qtr Cr 1011109910
    Interest Qtr Cr 111111
    Tax Qtr Cr 855869
    Net Profit Qtr Cr 171315152221
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 535618
    Operating Expenses Annual Cr 407354
    Operating Profit Annual in Cr 120235
    Depreciation Cr 3934
    Interest Annual Cr 22
    Tax Annual Cr 2452
    Net Profit Annual Cr 64176
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 129113
    Cash from Investing Activity Annual Cr -39-24
    Cash from Financing Annual Activity Cr -86-89
    Net Cash Flow Annual Cr 40
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 534527
    Fixed Assets Annual Cr 195188
    Total Non Current Assets Annual Cr 360338
    Total Current Assets Annual Cr 273270
    Total Assets Annual Cr 633608
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 101100
    ROE Annual % 1233
    ROCE Annual % 1642
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2445

    Thyrocare Technologies Technicals

    EMA & SMA

    Current Price
    ₹568.3
    14.5 (2.62%)
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹558.32
    • 50 Day
    • ₹551.05
    • 100 Day
    • ₹538.74
    • 200 Day
    • ₹552.07
    • 20 Day
    • ₹557.89
    • 50 Day
    • ₹560.72
    • 100 Day
    • ₹526.93
    • 200 Day
    • ₹518.91

    Thyrocare Technologies Resistance and Support

    PIVOT
    ₹566.07
    Resistance
    First Resistance ₹577.19
    Second Resistance ₹586.07
    Third Resistance ₹597.19
    RSI 55.48
    MFI 61.99
    MACD Single Line 2.53
    MACD 2.41
    Support
    First Resistance ₹557.19
    Second Resistance ₹546.07
    Third Resistance ₹537.19

    Thyrocare Technologies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 78,445 2,616,141 33.35
    Week 35,339 1,504,381 42.57
    1 Month 83,828 4,319,645 51.53
    6 Month 184,346 9,152,766 49.65

    Thyrocare Technologies Result Highlights

    Thyrocare Technologies Synopsis

    NSE-Medical-Services

    Thyrocare Tech. is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 486.46 Cr. and Equity Capital is Rs. 52.93 Cr. for the Year ended 31/03/2023. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.
    Market Cap 3,008
    Sales 491
    Shares in Float 1.53
    No of funds 47
    Yield 3.17
    Book Value 5.77
    U/D Vol ratio 1.1
    LTDebt / Equity
    Alpha -0.09
    Beta 0.52

    Thyrocare Technologies

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 71.14%71.14%71.14%71.14%
    Mutual Funds 12.04%7.03%7.3%6.81%
    Insurance Companies 1.08%1.08%1.08%1.85%
    Foreign Portfolio Investors 3.44%9.99%10.13%10.42%
    Financial Institutions/ Banks
    Individual Investors 9.42%8.38%8.07%7.28%
    Others 2.88%2.38%2.28%2.5%

    Thyrocare Technologies Management

    Name Designation
    Mr. Rahul Guha Managing Director & CEO
    Mr. Dharmil Sheth Non Executive Director
    Mr. Hardik Dedhia Non Executive Director
    Mr. Dhaval Shah Non Executive Director
    Mr. Gopalkrishna Shivram Hegde Independent Director
    Dr. Indumati Gopinathan Independent Director
    Dr. Neetin S Desai Independent Director

    Thyrocare Technologies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Thyrocare Technologies Corporate Action

    Date Purpose Remarks
    2023-08-01 Quarterly Results
    2023-05-23 Audited Results
    2023-04-07 Interim Dividend
    2023-02-03 Quarterly Results
    2022-11-11 Quarterly Results
    Date Purpose Remarks
    2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
    2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend

    Thyrocare Technologies MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 36540
    ICICI Prudential India Opportunities Fund Regular Growth 11294
    Nippon India Pharma Fund - Growth 5545
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3174
    Nippon India Retirement Fund - Wealth Creation Scheme - Regular Growth 2605
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Thyrocare Technologies FAQs

    What is Share Price of Thyrocare Technologies ?

    Thyrocare Technologies share price is ₹568 As on 30 September, 2023 | 18:37

    What is the Market Cap of Thyrocare Technologies ?

    The Market Cap of Thyrocare Technologies is ₹3008 Cr As on 30 September, 2023 | 18:37

    What is the P/E ratio of Thyrocare Technologies ?

    The P/E ratio of Thyrocare Technologies is 50.1 As on 30 September, 2023 | 18:37

    What is the PB ratio of Thyrocare Technologies ?

    The PB ratio of Thyrocare Technologies is 5.6 As on 30 September, 2023 | 18:37

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.